We further revealed the mechanism of action of the combinatorial treatment: β-elemene in combination with propranolol inhibits proliferation, migration, and angiogenesis of hemangioma by synergistically down-regulating the HIF-1-α/VEGFA signaling pathway (Fig. 7). The gene discussed is VEGFA; the disease is hemangioma.